- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Urology
Volume 2014 (2014), Article ID 932481, 5 pages
The Relationship between ALA16VAL Single Gene Polymorphism and Renal Cell Carcinoma
1Department of Urology, Gaziosmanpasa University Medical Faculty, Tokat 60100, Turkey
2Department of Biochemistry, Gaziosmanpasa University Medical Faculty, Tokat 60100, Turkey
3Department of Biostatistics and Medical Informatics, Medical Faculty, Sakarya University, Turkey
Received 29 June 2013; Accepted 2 December 2013; Published 23 January 2014
Academic Editor: Axel S. Merseburger
Copyright © 2014 Dogan Atilgan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. H. Landis, T. Murray, S. Bolden, and P. A. Wingo, “Cancer Statistics, 1999,” Ca: A Cancer Journal for Clinicians, vol. 49, no. 1, pp. 8–31, 1999.
- S. Störkel, J. N. Eble, K. Adlakha, et al., “Classification of renal cell carcinoma: workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC),” Cancer, vol. 80, pp. 987–989, 1997.
- S. C. Clifford, A. H. Prowse, N. A. Affara, C. H. Buys, and E. R. Maher, “Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis,” Genes Chromosomes Cancer, vol. 22, pp. 200–209, 1998.
- L. B. Barreiro, G. Laval, H. Quach, E. Patin, and L. Quintana-Murci, “Natural selection has driven population differentiation in modern humans,” Nature Genetics, vol. 40, no. 3, pp. 340–345, 2008.
- V. M. Ingram, “A specific chemical difference between the globins of normal human and sickle-cell anæmia hæmoglobin,” Nature, vol. 178, no. 4537, pp. 792–794, 1956.
- J. C. Chang and Y. W. Kan, “β0 thalassemia, a nonsense mutation in man,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 6, pp. 2886–2889, 1979.
- A. Hamosh, T. M. King, B. J. Rosenstein et al., “Cystic fibrosis patients bearing both the common missense mutation Gly→Asp at codon 551 and the ΔF508 mutation are clinically indistinguishable from ΔF508 homozygotes, except for decreased risk of meconium ileus,” American Journal of Human Genetics, vol. 51, no. 2, pp. 245–250, 1992.
- M. Fareed and M. Afzal, “Single nucleotide polymorphism in genome-wide association of human population: a tool for broad spectrum service,” Egyptian Journal of Medical Human Genetics, vol. 14, no. 2, pp. 123–134, 2013.
- P. E. Thomas, R. Klinger, L. I. Furlong, M. Hofmann-Apitius, and C. M. Friedrich, “Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiers,” BMC Bioinformatics, vol. 12, supplement 4, article S4, 2011.
- I. Fridovich, “The biology of oxygen radicals,” Science, vol. 201, no. 4359, pp. 875–880, 1978.
- J. S. Rosenblum, N. B. Gilula, and R. A. Lerner, “On signal sequence polymorphisms and diseases of distribution,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 9, pp. 4471–4473, 1996.
- M. Gago-Dominguez, J. E. Castelao, J.-M. Yuan, R. K. Ross, and M. C. Yu, “Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States),” Cancer Causes and Control, vol. 13, no. 3, pp. 287–293, 2002.
- M. Gago-Dominguez and J. E. Castelao, “Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights,” Free Radical Biology and Medicine, vol. 40, no. 4, pp. 721–733, 2006.
- L. Lusini, S. A. Tripodi, R. Rossi, et al., “Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma,” International Journal of Cancer, vol. 91, pp. 55–59, 2001.
- A. Bag and N. Bag, “Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 12, pp. 3298–3305, 2008.
- L. W. Oberley and G. R. Buettner, “Role of superoxide dismutase in cancer: a review,” Cancer Research, vol. 39, no. 4, pp. 1141–1149, 1979.
- T.-C. Chuang, J.-Y. Liu, C.-T. Lin et al., “Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy,” FEBS Letters, vol. 581, no. 23, pp. 4443–4449, 2007.
- J. J. Cullen, C. Weydert, M. M. Hinkhouse et al., “The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma,” Cancer Research, vol. 63, no. 6, pp. 1297–1303, 2003.
- H. Hu, M.-L. Luo, X.-L. Du et al., “Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas,” Chinese Medical Journal, vol. 120, no. 23, pp. 2092–2098, 2007.
- Y. Soini, M. Vakkala, K. Kahlos, P. Pääkkö, and V. Kinnula, “MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells,” Journal of Pathology, vol. 195, no. 2, pp. 156–162, 2001.
- M. Valko, M. Izakovic, M. Mazur, C. J. Rhodes, and J. Telser, “Role of oxygen radicals in DNA damage and cancer incidence,” Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 37–56, 2004.
- J. E. Klaunig and L. M. Kamendulis, “The role of oxidative stress in carcinogenesis,” Annual Review of Pharmacology and Toxicology, vol. 44, pp. 239–267, 2004.
- J. E. Klaunig, Y. Xu, S. Bachowski, and J. Jiang, “Free-radical oxygen-induced changes in chemical carcinogenesis,” in Free Radical Toxicology, K. B. Wallace, Ed., pp. 375–400, Taylor & Francis, London, UK, 1997.
- A. Gorman, A. McGowan, and T. G. Cotter, “Role of peroxide and superoxide anion during tumour cell apoptosis,” FEBS Letters, vol. 404, no. 1, pp. 27–33, 1997.
- C. F. Nathan and Z. A. Cohn, “Antitumor effects of hydrogen peroxide in vivo,” Journal of Experimental Medicine, vol. 154, no. 5, pp. 1539–1553, 1981.
- M. López-Lázaro, “Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy,” Cancer Letters, vol. 252, no. 1, pp. 1–8, 2007.
- A. Sutton, H. Khoury, C. Prip-Buus, C. Cepanec, D. Pessayre, and F. Degoul, “The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria,” Pharmacogenetics, vol. 13, no. 3, pp. 145–157, 2003.
- R. J. Hung, P. Boffetta, P. Brennan et al., “Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk,” Carcinogenesis, vol. 25, no. 6, pp. 973–978, 2004.
- M. Bergman, M. Ahnström, P. P. Wegman, and S. Wingren, “Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women,” Journal of Cancer Research and Clinical Oncology, vol. 131, no. 7, pp. 439–444, 2005.
- J. Zejnilovic, N. Akev, H. Yilmaz, and T. Isbir, “Association between manganese superoxide dismutase polymorphism and risk of lung cancer,” Cancer Genetics and Cytogenetics, vol. 189, no. 1, pp. 1–4, 2009.
- G. Liu, W. Zhou, S. Park et al., “The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms,” Cancer, vol. 101, no. 12, pp. 2802–2808, 2004.
- J. Dasgupta, S. Subbaram, K. M. Connor et al., “Manganese superoxide dismutase protects from TNF-α-induced apoptosis by increasing the steady-state production of H2O2,” Antioxidants and Redox Signaling, vol. 8, no. 7-8, pp. 1295–1305, 2006.
- S. Landi, F. Gemignani, M. Neri et al., “Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma,” International Journal of Cancer, vol. 120, no. 12, pp. 2739–2743, 2007.
- R. C. Millikan, J. Player, A. R. de Cotret et al., “Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites,” Breast Cancer Research, vol. 6, no. 4, pp. R264–R274, 2004.
- K. M. Egan, P. A. Thompson, L. Titus-Ernstoff, J. H. Moore, and C. B. Ambrosone, “MnSOD polymorphism and breast cancer in a population-based case-control study,” Cancer Letters, vol. 199, no. 1, pp. 27–33, 2003.
- C. B. Ambrosone, J. L. Freudenheim, P. A. Thompson et al., “Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer,” Cancer Research, vol. 59, no. 3, pp. 602–606, 1999.
- D. Kang, K.-M. Lee, K. P. Sue et al., “Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 8, pp. 1581–1586, 2007.
- H. Ergen, F. Narter, Ö. Timirci, and T. Isbir, “Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study,” Anticancer Research, vol. 27, no. 2, pp. 1227–1230, 2007.
- Z. Arsova-Sarafinovska, N. Matevska, D. Petrovski et al., “Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer,” Cell Biochemistry and Function, vol. 26, no. 7, pp. 771–777, 2008.
- B. Mikhak, D. J. Hunter, D. Spiegelman et al., “Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk,” Carcinogenesis, vol. 29, no. 12, pp. 2335–2340, 2008.
- K. Woodson, J. A. Tangrea, T. A. Lehman et al., “Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland),” Cancer Causes and Control, vol. 14, no. 6, pp. 513–518, 2003.
- J.-F. Yi, Y.-M. Li, T. Liu et al., “Mn-SOD and cuZn-SOD polymorphisms and interactions with risk factors in gastric cancer,” World Journal of Gastroenterology, vol. 16, no. 37, pp. 4738–4746, 2010.